Company intelligence / Profile preview

MPM BioImpact

Boston, Massachusetts, United Statesmpmbioimpact.com ↗

Ownership: Private
Employees: ~75
Development stage: Other

Overview

MPM BioImpact is a leading biotechnology investment firm specializing in creating and investing in innovative biotech companies developing life-saving drugs. The firm manages over $3 billion in assets across early-stage venture funds and public/private impact funds. Its investments span the full spectrum of drug development stages via its portfolio companies. Recent activities include taking Reunion Neuroscience private to advance clinical programs for mental health disorders[1][5][6].

Therapeutic areas: OncologyImmunologyPsychiatry
Modalities: Small moleculeAntibodyGene therapyRNA therapyCell therapy
Industry: Investors

Partnerships

Vertex Pharmaceuticals

Beyond the preview

Go deeper on MPM BioImpact.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MPM BioImpact.